share_log
Breakings ·  Jul 1 20:01
Humacyte Acellular Tissue Engineered Vessel (Atev™) Receives Fda’s Regenerative Medicine Advanced Therapy (Rmat) Designation for Patients With Advanced Peripheral Artery Disease (Pad)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment